Review

*Author for correspondence:

E-mail Address: christian.hedrich@uniklinikum-dresden.de

Pediatric Rheumatology & Immunology, Klinik und Poliklinik für Kinder- und Jugendmedizin, Universitätsklinikum Carl Gustav Carus, TU Dresden, Dresden, Germany

Search for more papers by this author

Katrin Mäbert

Pediatric Rheumatology & Immunology, Klinik und Poliklinik für Kinder- und Jugendmedizin, Universitätsklinikum Carl Gustav Carus, TU Dresden, Dresden, Germany

Search for more papers by this author

Thomas Rauen

Department of Nephrology & Clinical Immunology, RWTH University Hospital, Aachen, Germany

Search for more papers by this author

George C Tsokos

Division of Rheumatology, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA

Search for more papers by this author

Published Online:25 Nov 2016https://doi.org/10.2217/epi-2016-0096

View article

Abstract

Systemic lupus erythematosus (SLE) is a systemic autoimmune disease facilitated by aberrant immune responses directed against cells and tissues, resulting in inflammation and organ damage. In the majority of patients, genetic predisposition is accompanied by additional factors conferring disease expression. While the exact molecular mechanisms remain elusive, epigenetic alterations in immune cells have been demonstrated to play a key role in disease pathogenesis through the dysregulation of gene expression. Since epigenetic marks are dynamic, allowing cells and tissues to differentiate and adjust, they can be influenced by environmental factors and also be targeted in therapeutic interventions. Here, we summarize reports on DNA methylation patterns in SLE, underlying molecular defects and their effect on immune cell function. We discuss the potential of DNA methylation as biomarker or therapeutic target in SLE.

Keywords:

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

1 Tsokos GC. Systemic lupus erythematosus. N. Engl. J. Med. 365(22), 2110–2121 (2011).Crossref, Medline, CAS, Google Scholar
2 Crispin JC, Hedrich CM, Tsokos GC. Gene-function studies in systemic lupus erythematosus. Nat. Rev. Rheumatol. 9(8), 476–484 (2013).Crossref, Medline, CAS, Google Scholar
3 Javierre BM, Fernandez AF, Richter J et al. Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res. 20(2), 170–179 (2010). •• The influence of DNA methylation on systemic lupus erythematosus (SLE) disease expression is demonstrated in genetically identical but disease discordant twins.Crossref, Medline, CAS, Google Scholar
4 Javierre BM, Hernando H, Ballestar E. Environmental triggers and epigenetic deregulation in autoimmune disease. Discov. Med. 12(67), 535–545 (2011).Medline, Google Scholar
5 Hedrich CM. Systemic Lupus Erythematosus. Elsevier, 255 (2016).Crossref, Google Scholar
6 Hedrich CM, Crispin JC, Tsokos GC. Epigenetic regulation of cytokine expression in systemic lupus erythematosus with special focus on T cells. Autoimmunity 47(4), 234–241 (2014).Crossref, Medline, CAS, Google Scholar
7 Hedrich CM, Tsokos GC. Epigenetic mechanisms in systemic lupus erythematosus and other autoimmune diseases. Trends Mol. Med. 17(12), 714–724 (2011).Crossref, Medline, CAS, Google Scholar
8 Ballestar E. An introduction to epigenetics. Adv. Exp. Med. Biol. 711, 1–11 (2011).Crossref, Medline, CAS, Google Scholar
9 Hofmann SR, Rosen-Wolff A, Tsokos GC, Hedrich CM. Biological properties and regulation of IL-10 related cytokines and their contribution to autoimmune disease and tissue injury. Clin. Immunol. 143(2), 116–127 (2012).Crossref, Medline, CAS, Google Scholar
10 Hedrich CM, Bream JH. Cell type-specific regulation of IL-10 expression in inflammation and disease. Immunol. Res. 47(1–3), 185–206 (2010).Crossref, Medline, CAS, Google Scholar
11 Ballestar E. Epigenetic alterations in autoimmune rheumatic diseases. Nat. Rev. Rheumatol. 7(5), 263–271 (2011).Crossref, Medline, CAS, Google Scholar
12 Ooi SK, O'donnell AH, Bestor TH. Mammalian cytosine methylation at a glance. J. Cell Sci. 122(Pt 16), 2787–2791 (2009).Crossref, Medline, CAS, Google Scholar
13 Brenner C, Fuks F. DNA methyltransferases: facts, clues, mysteries. Curr. Top. Microbiol. Immunol. 301, 45–66 (2006).Medline, CAS, Google Scholar
14 Brenner C, Fuks F. A methylation rendezvous: reader meets writers. Dev. Cell 12(6), 843–844 (2007).Crossref, Medline, CAS, Google Scholar
15 Brooks WH, Le Dantec C, Pers JO, Youinou P, Renaudineau Y. Epigenetics and autoimmunity. J. Autoimmun. 34(3), J207–J219 (2010).Crossref, Medline, CAS, Google Scholar
16 Meroni PL, Penatti AE. Epigenetics and systemic lupus erythematosus: unmet needs. Clin. Rev. Allergy Immunol. 50(3), 367–376 (2016).Crossref, Medline, CAS, Google Scholar
17 Xiao G, Zuo X. Epigenetics in systemic lupus erythematosus. Biomed. Rep. 4(2), 135–139 (2016).Crossref, Medline, CAS, Google Scholar
18 Josefowicz SZ. Regulators of chromatin state and transcription in CD4 T-cell polarization. Immunology 139(3), 299–308 (2013).Crossref, Medline, CAS, Google Scholar
19 Lim PS, Shannon MF, Hardy K. Epigenetic control of inducible gene expression in the immune system. Epigenomics 2(6), 775–795 (2010).Link, CAS, Google Scholar
20 Rothenberg EV. The chromatin landscape and transcription factors in T cell programming. Trends Immunol. 35(5), 195–204 (2014).Crossref, Medline, CAS, Google Scholar
21 Hillhouse EE, Lesage S. A comprehensive review of the phenotype and function of antigen-specific immunoregulatory double negative T cells. J. Autoimmun. 40, 58–65 (2013).Crossref, Medline, CAS, Google Scholar
22 Martina MN, Noel S, Saxena A, Rabb H, Hamad AR. Double negative (DN) alphabeta T cells: misperception and overdue recognition. Immunol. Cell Biol. 93(3), 305–310 (2015).Crossref, Medline, CAS, Google Scholar
23 Schoenborn JR, Dorschner MO, Sekimata M et al. Comprehensive epigenetic profiling identifies multiple distal regulatory elements directing transcription of the gene encoding interferon-gamma. Nat. Immunol. 8(7), 732–742 (2007).Crossref, Medline, CAS, Google Scholar
24 Schoenborn JR, Wilson CB. Regulation of interferon-gamma during innate and adaptive immune responses. Adv. Immunol. 96, 41–101 (2007).Crossref, Medline, CAS, Google Scholar
25 Hedrich CM, Crispin JC, Rauen T et al. cAMP response element modulator alpha controls IL2 and IL17A expression during CD4 lineage commitment and subset distribution in lupus. Proc. Natl Acad. Sci. USA 109(41), 16606–16611 (2012). •• Diametric effects of the transcription factor cyclic adenosine-monophosphate response element modulator α on DNA methylation patterns and gene expression of IL2 and IL17 are documented.Crossref, Medline, CAS, Google Scholar
26 Rauen T, Hedrich CM, Juang YT, Tenbrock K, Tsokos GC. cAMP-responsive element modulator (CREM)alpha protein induces interleukin 17A expression and mediates epigenetic alterations at the interleukin-17A gene locus in patients with systemic lupus erythematosus. J. Biol. Chem. 286(50), 43437–43446 (2011).Crossref, Medline, CAS, Google Scholar
27 Apostolidis SA, Rauen T, Hedrich CM, Tsokos GC, Crispin JC. Protein phosphatase 2A enables expression of interleukin 17 (IL-17) through chromatin remodeling. J. Biol. Chem. 288(37), 26775–26784 (2013).Crossref, Medline, CAS, Google Scholar
28 Hedrich CM, Crispin JC, Rauen T et al. cAMP responsive element modulator (CREM) alpha mediates chromatin remodeling of CD8 during the generation of CD3+ CD4- CD8- T cells. J. Biol. Chem. 289(4), 2361–2370 (2014).Crossref, Medline, CAS, Google Scholar
29 Hedrich CM, Rauen T, Crispin JC et al. cAMP-responsive element modulator alpha (CREMalpha) trans-represses the transmembrane glycoprotein CD8 and contributes to the generation of CD3+CD4-CD8- T cells in health and disease. J. Biol. Chem. 288(44), 31880–31887 (2013).Crossref, Medline, CAS, Google Scholar
30 Crispin JC, Oukka M, Bayliss G et al. Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J. Immunol. 181(12), 8761–8766 (2008).Crossref, Medline, CAS, Google Scholar
31 Rodriguez-Rodriguez N, Apostolidis SA, Penaloza-Macmaster P et al. Programmed cell death 1 and Helios distinguish TCR-alphabeta+ double-negative (CD4-CD8-) T cells that derive from self-reactive CD8 T cells. J. Immunol. 194(9), 4207–4214 (2015).Crossref, Medline, CAS, Google Scholar
32 Liu Y, Chen Y, Richardson B. Decreased DNA methyltransferase levels contribute to abnormal gene expression in “senescent” CD4(+)CD28(-) T cells. Clin. Immunol. 132(2), 257–265 (2009).Crossref, Medline, CAS, Google Scholar
33 Lal G, Zhang N, Van Der Touw W et al. Epigenetic regulation of Foxp3 expression in regulatory T cells by DNA methylation. J. Immunol. 182(1), 259–273 (2009).Crossref, Medline, CAS, Google Scholar
34 Zhao M, Tang J, Gao F et al. Hypomethylation of IL10 and IL13 promoters in CD4+ T cells of patients with systemic lupus erythematosus. J. Biomed. Biotechnol. 2010, 931018 (2010).Crossref, Medline, Google Scholar
35 Hedrich CM, Rauen T, Apostolidis SA et al. Stat3 promotes IL-10 expression in lupus T cells through trans-activation and chromatin remodeling. Proc. Natl Acad. Sci. USA 111(37), 13457–13462 (2014). • Interactions between Stat3 and the epigenetic modifier p300 is demonstrated and linked to increased gene expression in SLE.Crossref, Medline, CAS, Google Scholar
36 Rauen T, Hedrich CM, Tenbrock K, Tsokos GC. cAMP responsive element modulator: a critical regulator of cytokine production. Trends Mol. Med. 19(4), 262–269 (2013).Crossref, Medline, CAS, Google Scholar
37 Ohl K, Tenbrock K. Inflammatory cytokines in systemic lupus erythematosus. J. Biomed. Biotechnol. 2011, 432595 (2011).Medline, Google Scholar
38 Peng H, Wang W, Zhou M, Li R, Pan HF, Ye DQ. Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosus. Clin. Rheumatol. 32(9), 1255–1266 (2013).Crossref, Medline, Google Scholar
39 Llorente L, Richaud-Patin Y, Garcia-Padilla C et al. Clinical and biologic effects of anti-interleukin-10 monoclonal antibody administration in systemic lupus erythematosus. Arthritis Rheum. 43(8), 1790–1800 (2000).Crossref, Medline, CAS, Google Scholar
40 Apostolidis SA, Crispin JC, Tsokos GC. IL-17-producing T cells in lupus nephritis. Lupus 20(2), 120–124 (2011).Crossref, Medline, CAS, Google Scholar
41 Apostolidis SA, Lieberman LA, Kis-Toth K, Crispin JC, Tsokos GC. The dysregulation of cytokine networks in systemic lupus erythematosus. J. Interferon Cytokine Res. 31(10), 769–779 (2011).Crossref, Medline, CAS, Google Scholar
42 Absher DM, Li X, Waite LL et al. Genome-wide DNA methylation analysis of systemic lupus erythematosus reveals persistent hypomethylation of interferon genes and compositional changes to CD4+ T-cell populations. PLoS Genet. 9(8), e1003678 (2013).Crossref, Medline, CAS, Google Scholar
43 Coit P, Yalavarthi S, Ognenovski M et al. Epigenome profiling reveals significant DNA demethylation of interferon signature genes in lupus neutrophils. J. Autoimmun. 58, 59–66 (2015).Crossref, Medline, CAS, Google Scholar
44 Crow MK, Olferiev M, Kirou KA. Targeting of type I interferon in systemic autoimmune diseases. Transl. Res. 165(2), 296–305 (2015).Crossref, Medline, CAS, Google Scholar
45 Rich SA. Human lupus inclusions and interferon. Science 213(4509), 772–775 (1981).Crossref, Medline, CAS, Google Scholar
46 Perl A. Mechanisms of viral pathogenesis in rheumatic disease. Ann. Rheum. Dis. 58(8), 454–461 (1999).Crossref, Medline, CAS, Google Scholar
47 Yoshiki T, Mellors RC, Strand M, August JT. The viral envelope glycoprotein of murine leukemia virus and the pathogenesis of immune complex glomerulonephritis of New Zealand mice. J. Exp. Med. 140(4), 1011–1027 (1974).Crossref, Medline, CAS, Google Scholar
48 Krieg AM, Steinberg AD. Analysis of thymic endogenous retroviral expression in murine lupus. Genetic and immune studies. J. Clin. Invest. 86(3), 809–816 (1990).Crossref, Medline, CAS, Google Scholar
49 Caza TN, Fernandez DR, Talaber G et al. HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE. Ann. Rheum. Dis. 73(10), 1888–1897 (2014).Crossref, Medline, CAS, Google Scholar
50 Perl A, Colombo E, Dai H et al. Antibody reactivity to the HRES-1 endogenous retroviral element identifies a subset of patients with systemic lupus erythematosus and overlap syndromes. Correlation with antinuclear antibodies and HLA class II alleles. Arthritis Rheum. 38(11), 1660–1671 (1995).Crossref, Medline, CAS, Google Scholar
51 Magistrelli C, Samoilova E, Agarwal RK et al. Polymorphic genotypes of the HRES-1 human endogenous retrovirus locus correlate with systemic lupus erythematosus and autoreactivity. Immunogenetics 49(10), 829–834 (1999).Crossref, Medline, CAS, Google Scholar
52 Pullmann R Jr., Bonilla E, Phillips PE, Middleton FA, Perl A. Haplotypes of the HRES-1 endogenous retrovirus are associated with development and disease manifestations of systemic lupus erythematosus. Arthritis Rheum. 58(2), 532–540 (2008).Crossref, Medline, CAS, Google Scholar
53 Nakkuntod J, Avihingsanon Y, Mutirangura A, Hirankarn N. Hypomethylation of LINE-1 but not Alu in lymphocyte subsets of systemic lupus erythematosus patients. Clin. Chim. Acta 412(15–16), 1457–1461 (2011).Crossref, Medline, CAS, Google Scholar
54 Garaud S, Le Dantec C, Jousse-Joulin S et al. IL-6 modulates CD5 expression in B cells from patients with lupus by regulating DNA methylation. J. Immunol. 182(9), 5623–5632 (2009).Crossref, Medline, CAS, Google Scholar
55 Fali T, Le Dantec C, Thabet Y et al. DNA methylation modulates HRES1/p28 expression in B cells from patients with Lupus. Autoimmunity 47(4), 265–271 (2014). • The influence of altered DNA methylation on increased transcriptional activity of the HRES1 locus in SLE is demonstrated.Crossref, Medline, CAS, Google Scholar
56 Lu Q, Wu A, Richardson BC. Demethylation of the same promoter sequence increases CD70 expression in lupus T cells and T cells treated with lupus-inducing drugs. J. Immunol. 174(10), 6212–6219 (2005).Crossref, Medline, CAS, Google Scholar
57 Singer NG, Richardson BC, Powers D et al. Role of the CD6 glycoprotein in antigen-specific and autoreactive responses of cloned human T lymphocytes. Immunology 88(4), 537–543 (1996).Medline, CAS, Google Scholar
58 Zhao M, Sun Y, Gao F et al. Epigenetics and SLE: RFX1 downregulation causes CD11a and CD70 overexpression by altering epigenetic modifications in lupus CD4+ T cells. J. Autoimmun. 35(1), 58–69 (2010).Crossref, Medline, Google Scholar
59 Lu Q, Wu A, Tesmer L, Ray D, Yousif N, Richardson B. Demethylation of CD40LG on the inactive X in T cells from women with lupus. J. Immunol. 179(9), 6352–6358 (2007).Crossref, Medline, CAS, Google Scholar
60 Strickland FM, Li Y, Johnson K, Sun Z, Richardson BC. CD4(+) T cells epigenetically modified by oxidative stress cause lupus-like autoimmunity in mice. J. Autoimmun. 62, 75–80 (2015).Crossref, Medline, CAS, Google Scholar
61 Garaud S, Youinou P, Renaudineau Y. DNA methylation and B-cell autoreactivity. Adv. Exp. Med. Biol. 711, 50–60 (2011).Crossref, Medline, CAS, Google Scholar
62 Renaudineau Y, Beauvillard D, Padelli M, Brooks WH, Youinou P. Epigenetic alterations and autoimmune disease. J. Dev. Orig. Health Dis. 2(5), 258–264 (2011).Crossref, Medline, CAS, Google Scholar
63 Renaudineau Y, Youinou P. Epigenetics and autoimmunity, with special emphasis on methylation. Keio J. Med. 60(1), 10–16 (2011).Crossref, Medline, CAS, Google Scholar
64 Kaplan MJ, Lu Q, Wu A, Attwood J, Richardson B. Demethylation of promoter regulatory elements contributes to perforin overexpression in CD4+ lupus T cells. J. Immunol. 172(6), 3652–3661 (2004).Crossref, Medline, CAS, Google Scholar
65 Sawalha AH, Wang L, Nadig A et al. Sex-specific differences in the relationship between genetic susceptibility, T cell DNA demethylation and lupus flare severity. J. Autoimmun. 38(2–3), J216–222 (2012).Crossref, Medline, CAS, Google Scholar
66 Liu Y, Kuick R, Hanash S, Richardson B. DNA methylation inhibition increases T cell KIR expression through effects on both promoter methylation and transcription factors. Clin. Immunol. 130(2), 213–224 (2009).Crossref, Medline, CAS, Google Scholar
67 Basu D, Liu Y, Wu A et al. Stimulatory and inhibitory killer Ig-like receptor molecules are expressed and functional on lupus T cells. J. Immunol. 183(5), 3481–3487 (2009).Crossref, Medline, CAS, Google Scholar
68 Sunahori K, Juang YT, Tsokos GC. Methylation status of CpG islands flanking a cAMP response element motif on the protein phosphatase 2Ac alpha promoter determines CREB binding and activity. J. Immunol. 182(3), 1500–1508 (2009).Crossref, Medline, CAS, Google Scholar
69 Sunahori K, Nagpal K, Hedrich CM, Mizui M, Fitzgerald LM, Tsokos GC. The catalytic subunit of protein phosphatase 2A (PP2Ac) promotes DNA hypomethylation by suppressing the phosphorylated mitogen-activated protein kinase/extracellular signal-regulated kinase (ERK) kinase (MEK)/phosphorylated ERK/DNMT1 protein pathway in T-cells from controls and systemic lupus erythematosus patients. J. Biol. Chem. 288(30), 21936–21944 (2013).Crossref, Medline, CAS, Google Scholar
70 Moulton VR, Holcomb DR, Zajdel MC, Tsokos GC. Estrogen upregulates cyclic AMP response element modulator alpha expression and downregulates interleukin-2 production by human T lymphocytes. Mol. Med. 18, 370–378 (2012).Crossref, Medline, CAS, Google Scholar
71 Moulton VR, Tsokos GC. Why do women get lupus? Clin. Immunol. 144(1), 53–56 (2012).Crossref, Medline, CAS, Google Scholar
72 Tedeschi SK, Bermas B, Costenbader KH. Sexual disparities in the incidence and course of SLE and RA. Clin. Immunol. 149(2), 211–218 (2013).Crossref, Medline, CAS, Google Scholar
73 Liu HW, Lin HL, Yen JH et al. Demethylation within the proximal promoter region of human estrogen receptor alpha gene correlates with its enhanced expression: Implications for female bias in lupus. Mol. Immunol. 61(1), 28–37 (2014).Crossref, Medline, CAS, Google Scholar
74 Hedrich CM, Rauen T, Tsokos GC. cAMP-responsive element modulator (CREM)alpha protein signaling mediates epigenetic remodeling of the human interleukin-2 gene: implications in systemic lupus erythematosus. J. Biol. Chem. 286(50), 43429–43436 (2011).Crossref, Medline, CAS, Google Scholar
75 Ngalamika O, Liang G, Zhao M et al. Peripheral whole blood FOXP3 TSDR methylation: a potential marker in severity assessment of autoimmune diseases and chronic infections. Immunol. Invest. 44(2), 126–136 (2015).Crossref, Medline, CAS, Google Scholar
76 Rauen T, Grammatikos AP, Hedrich CM et al. cAMP-responsive element modulator alpha (CREMalpha) contributes to decreased Notch-1 expression in T cells from patients with active systemic lupus erythematosus (SLE). J. Biol. Chem. 287(51), 42525–42532 (2012).Crossref, Medline, CAS, Google Scholar
77 Chen H, Fan J, Shou Q, Zhang L, Ma H, Fan Y. Hypermethylation of glucocorticoid receptor gene promoter results in glucocorticoid receptor gene low expression in peripheral blood mononuclear cells of patients with systemic lupus erythematosus. Rheumatol. Int. 35(8), 1335–1342 (2015).Crossref, Medline, CAS, Google Scholar
78 Renauer PA, Coit P, Sawalha AH. The DNA methylation signature of human TCRalphabeta⁺CD4^-CD8^- double negative T cells reveals CG demethylation and a unique epigenetic architecture permissive to a broad stimulatory immune response. Clin. Immunol. 156(1), 19–27 (2015).Crossref, Medline, CAS, Google Scholar
79 Andreae J, Tripmacher R, Weltrich R et al. Effect of glucocorticoid therapy on glucocorticoid receptors in children with autoimmune diseases. Pediatr. Res. 49(1), 130–135 (2001).Crossref, Medline, CAS, Google Scholar
80 Jiang T, Liu S, Tan M et al. The phase-shift mutation in the glucocorticoid receptor gene: potential etiologic significance of neuroendocrine mechanisms in lupus nephritis. Clin. Chim. Acta 313(1–2), 113–117 (2001).Crossref, Medline, CAS, Google Scholar
81 Piotrowski P, Burzynski M, Lianeri M et al. Glucocorticoid receptor beta splice variant expression in patients with high and low activity of systemic lupus erythematosus. Folia Histochem. Cytobiol. 45(4), 339–342 (2007).Medline, CAS, Google Scholar
82 Ehrlich M, Ehrlich KC. DNA cytosine methylation and hydroxymethylation at the borders. Epigenomics 6(6), 563–566 (2014).Link, CAS, Google Scholar
83 Hackett JA, Sengupta R, Zylicz JJ et al. Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. Science 339(6118), 448–452 (2013).Crossref, Medline, CAS, Google Scholar
84 Hahn MA, Qiu R, Wu X et al. Dynamics of 5-hydroxymethylcytosine and chromatin marks in mammalian neurogenesis. Cell Rep. 3(2), 291–300 (2013).Crossref, Medline, CAS, Google Scholar
85 Neri F, Incarnato D, Krepelova A et al. Genome-wide analysis identifies a functional association of Tet1 and Polycomb repressive complex 2 in mouse embryonic stem cells. Genome Biol. 14(8), R91 (2013).Crossref, Medline, Google Scholar
86 Song CX, Szulwach KE, Fu Y et al. Selective chemical labeling reveals the genome-wide distribution of 5-hydroxymethylcytosine. Nat. Biotechnol. 29(1), 68–72 (2011).Crossref, Medline, CAS, Google Scholar
87 Shukla A, Sehgal M, Singh TR. Hydroxymethylation and its potential implication in DNA repair system: a review and future perspectives. Gene 564(2), 109–118 (2015).Crossref, Medline, CAS, Google Scholar
88 Schomacher L. Mammalian DNA demethylation: multiple faces and upstream regulation. Epigenetics 8(7), 679–684 (2013).Crossref, Medline, CAS, Google Scholar
89 Tahiliani M, Koh KP, Shen Y et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324(5929), 930–935 (2009).Crossref, Medline, CAS, Google Scholar
90 Gao Y, Chen J, Li K et al. Replacement of Oct4 by Tet1 during iPSC induction reveals an important role of DNA methylation and hydroxymethylation in reprogramming. Cell Stem Cell 12(4), 453–469 (2013).Crossref, Medline, CAS, Google Scholar
91 Sui W, Tan Q, Yang M et al. Genome-wide analysis of 5-hmC in the peripheral blood of systemic lupus erythematosus patients using an hMeDIP-chip. Int. J. Mol. Med. 35(5), 1467–1479 (2015).Crossref, Medline, CAS, Google Scholar
92 Xu Y, Wu F, Tan L et al. Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells. Mol. Cell 42(4), 451–464 (2011).Crossref, Medline, CAS, Google Scholar
93 Straussman R, Nejman D, Roberts D et al. Developmental programming of CpG island methylation profiles in the human genome. Nat. Struct. Mol. Biol. 16(5), 564–571 (2009). • The potential influence of DNA hydroxymethylation on altered gene expression in SLE is demonstrated.Crossref, Medline, CAS, Google Scholar
94 Zhao M, Wang J, Liao W et al. Increased 5-hydroxymethylcytosine in CD4(⁺) T cells in systemic lupus erythematosus. J. Autoimmun. 69, 64–73 (2016).Crossref, Medline, Google Scholar
95 Januchowski R, Wudarski M, Chwalinska-Sadowska H, Jagodzinski PP. Prevalence of ZAP-70, LAT, SLP-76, and DNA methyltransferase 1 expression in CD4⁺ T cells of patients with systemic lupus erythematosus. Clin. Rheumatol. 27(1), 21–27 (2008).Crossref, Medline, Google Scholar
96 Lei W, Luo Y, Lei W et al. Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand. J. Rheumatol. 38(5), 369–374 (2009).Crossref, Medline, CAS, Google Scholar
97 Balada E, Ordi-Ros J, Serrano-Acedo S, Martinez-Lostao L, Rosa-Leyva M, Vilardell-Tarres M. Transcript levels of DNA methyltransferases DNMT1, DNMT3A and DNMT3B in CD4⁺ T cells from patients with systemic lupus erythematosus. Immunology 124(3), 339–347 (2008).Crossref, Medline, CAS, Google Scholar
98 Denli AM, Tops BB, Plasterk RH, Ketting RF, Hannon GJ. Processing of primary microRNAs by the Microprocessor complex. Nature 432(7014), 231–235 (2004).Crossref, Medline, CAS, Google Scholar
99 Gregory RI, Yan KP, Amuthan G et al. The microprocessor complex mediates the genesis of microRNAs. Nature 432(7014), 235–240 (2004).Crossref, Medline, CAS, Google Scholar
100 Grishok A, Pasquinelli AE, Conte D et al. Genes and mechanisms related to RNA interference regulate expression of the small temporal RNAs that control C. elegans developmental timing. Cell 106(1), 23–34 (2001).Crossref, Medline, CAS, Google Scholar
101 Hutvagner G, Mclachlan J, Pasquinelli AE, Balint E, Tuschl T, Zamore PD. A cellular function for the RNA-interference enzyme Dicer in the maturation of the let-7 small temporal RNA. Science 293(5531), 834–838 (2001).Crossref, Medline, CAS, Google Scholar
102 Fabian MR, Sonenberg N, Filipowicz W. Regulation of mRNA translation and stability by microRNAs. Annu. Rev. Biochem. 79, 351–379 (2010).Crossref, Medline, CAS, Google Scholar
103 Pillai RS, Bhattacharyya SN, Filipowicz W. Repression of protein synthesis by miRNAs: how many mechanisms? Trends Cell Biol. 17(3), 118–126 (2007).Crossref, Medline, CAS, Google Scholar
104 Fabbri M, Garzon R, Cimmino A et al. MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B. Proc. Natl Acad. Sci. USA 104(40), 15805–15810 (2007).Crossref, Medline, CAS, Google Scholar
105 Garzon R, Liu S, Fabbri M et al. MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1. Blood 113(25), 6411–6418 (2009).Crossref, Medline, CAS, Google Scholar
106 Ng EK, Tsang WP, Ng SS et al. MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer. Br. J. Cancer 101(4), 699–706 (2009).Crossref, Medline, CAS, Google Scholar
107 Zhao S, Wang Y, Liang Y et al. MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1. Arthritis Rheum. 63(5), 1376–1386 (2011). • Reduced MAPK activity in T cells is linked to altered DNA methylation and gene expression in SLE.Crossref, Medline, CAS, Google Scholar
108 Gorelik G, Sawalha AH, Patel D, Johnson K, Richardson B. T cell PKCdelta kinase inactivation induces lupus-like autoimmunity in mice. Clin. Immunol. 158(2), 193–203 (2015).Crossref, Medline, CAS, Google Scholar
109 Gorelik GJ, Yarlagadda S, Patel DR, Richardson BC. Protein kinase Cdelta oxidation contributes to ERK inactivation in lupus T cells. Arthritis Rheum. 64(9), 2964–2974 (2012).Crossref, Medline, CAS, Google Scholar
110 Li Y, Zhao M, Yin H et al. Overexpression of the growth arrest and DNA damage-induced 45alpha gene contributes to autoimmunity by promoting DNA demethylation in lupus T cells. Arthritis Rheum. 62(5), 1438–1447 (2010).Crossref, Medline, CAS, Google Scholar
111 Rai K, Huggins IJ, James SR, Karpf AR, Jones DA, Cairns BR. DNA demethylation in zebrafish involves the coupling of a deaminase, a glycosylase, and gadd45. Cell 135(7), 1201–1212 (2008).Crossref, Medline, CAS, Google Scholar
112 Li Y, Huang C, Zhao M et al. A possible role of HMGB1 in DNA demethylation in CD4⁺ T cells from patients with systemic lupus erythematosus. Clin. Dev. Immunol. 2013, 206298 (2013). • Applying whole-genome mapping of transcription factor recruitment, transcriptional activity, DNA methylation and histone modification patterns, the authors provide evidence for interconnections between these mechanisms.Medline, Google Scholar
113 Consortium EP. An integrated encyclopedia of DNA elements in the human genome. Nature 489(7414), 57–74 (2012).Crossref, Medline, Google Scholar
114 Farh KK, Marson A, Zhu J et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 518(7539), 337–343 (2015).Crossref, Medline, CAS, Google Scholar
115 Roadmap Epigenomics C, Kundaje A, Meuleman W et al. Integrative analysis of 111 reference human epigenomes. Nature 518(7539), 317–330 (2015). •• Interactions between the transcription factor RFX1 and the epigenetic modifiers SUV39H1, HDAC1 and DNMT1 is demonstrated and linked to altered gene expression in SLE.Crossref, Medline, Google Scholar
116 Zhao M, Liu S, Luo S et al. DNA methylation and mRNA and microRNA expression of SLE CD4⁺ T cells correlate with disease phenotype. J. Autoimmun. 54, 127–136 (2014).Crossref, Medline, CAS, Google Scholar
117 Zhao M, Wu X, Zhang Q et al. RFX1 regulates CD70 and CD11a expression in lupus T cells by recruiting the histone methyltransferase SUV39H1. Arthritis Res. Ther. 12(6), R227 (2010).Crossref, Medline, CAS, Google Scholar
118 Hedrich CM, Rauen T, Kis-Toth K, Kyttaris VC, Tsokos GC. cAMP-responsive element modulator alpha (CREMalpha) suppresses IL-17F protein expression in T lymphocytes from patients with systemic lupus erythematosus (SLE). J. Biol. Chem. 287(7), 4715–4725 (2012).Crossref, Medline, CAS, Google Scholar
119 Juang YT, Rauen T, Wang Y et al. Transcriptional activation of the cAMP-responsive modulator promoter in human T cells is regulated by protein phosphatase 2A-mediated dephosphorylation of SP-1 and reflects disease activity in patients with systemic lupus erythematosus. J. Biol. Chem. 286(3), 1795–1801 (2011).Crossref, Medline, CAS, Google Scholar
120 Vicart A, Lefebvre T, Imbert J, Fernandez A, Kahn-Perles B. Increased chromatin association of Sp1 in interphase cells by PP2A-mediated dephosphorylations. J. Mol. Biol. 364(5), 897–908 (2006).Crossref, Medline, CAS, Google Scholar
121 Ichinose K, Rauen T, Juang YT et al. Cutting edge: calcium/calmodulin-dependent protein kinase type IV is essential for mesangial cell proliferation and lupus nephritis. J. Immunol. 187(11), 5500–5504 (2011).Crossref, Medline, CAS, Google Scholar
122 Ichinose K, Ushigusa T, Nishino A et al. Lupus nephritis IgG induction of calcium/calmodulin-dependent protein kinase IV expression in podocytes and alteration of their function. Arthritis Rheumatol. 68(4), 944–952 (2016).Crossref, Medline, CAS, Google Scholar
123 Koga T, Ichinose K, Mizui M, Crispin JC, Tsokos GC. Calcium/calmodulin-dependent protein kinase IV suppresses IL-2 production and regulatory T cell activity in lupus. J. Immunol. 189(7), 3490–3496 (2012).Crossref, Medline, CAS, Google Scholar
124 Koga T, Mizui M, Yoshida N et al. KN-93, an inhibitor of calcium/calmodulin-dependent protein kinase IV, promotes generation and function of Foxp3(⁺) regulatory T cells in MRL/lpr mice. Autoimmunity 47(7), 445–450 (2014).Crossref, Medline, CAS, Google Scholar
125 Koga T, Otomo K, Mizui M et al. Calcium/calmodulin-dependent kinase IV facilitates the recruitment of interleukin-17-producing cells to target organs through the CCR6/CCL20 axis in Th17 cell-driven inflammatory diseases. Arthritis Rheumatol. 68(8), 1981–1988 (2016).Crossref, Medline, CAS, Google Scholar
126 Racioppi L, Means AR. Calcium/calmodulin-dependent kinase IV in immune and inflammatory responses: novel routes for an ancient traveller. Trends Immunol. 29(12), 600–607 (2008).Crossref, Medline, CAS, Google Scholar
127 Ichinose K, Juang YT, Crispin JC, Kis-Toth K, Tsokos GC. Suppression of autoimmunity and organ pathology in lupus-prone mice upon inhibition of calcium/calmodulin-dependent protein kinase type IV. Arthritis Rheum. 63(2), 523–529 (2011).Crossref, Medline, CAS, Google Scholar
128 Juang YT, Wang Y, Solomou EE et al. Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV. J. Clin. Invest. 115(4), 996–1005 (2005).Crossref, Medline, CAS, Google Scholar
129 He YF, Li BZ, Li Z et al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 333(6047), 1303–1307 (2011).Crossref, Medline, CAS, Google Scholar
130 Ito S, Shen L, Dai Q et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333(6047), 1300–1303 (2011).Crossref, Medline, CAS, Google Scholar
131 Kriaucionis S, Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science 324(5929), 929–930 (2009).Crossref, Medline, CAS, Google Scholar
132 Hashimoto H, Liu Y, Upadhyay AK et al. Recognition and potential mechanisms for replication and erasure of cytosine hydroxymethylation. Nucleic Acids Res. 40(11), 4841–4849 (2012).Crossref, Medline, CAS, Google Scholar
133 Ko M, An J, Rao A. DNA methylation and hydroxymethylation in hematologic differentiation and transformation. Curr. Opin. Cell Biol. 37, 91–101 (2015).Crossref, Medline, CAS, Google Scholar
134 Pernis AB. Estrogen and CD4⁺ T cells. Curr. Opin. Rheumatol. 19(5), 414–420 (2007).Crossref, Medline, CAS, Google Scholar
135 Tiniakou E, Costenbader KH, Kriegel MA. Sex-specific environmental influences on the development of autoimmune diseases. Clin. Immunol. 149(2), 182–191 (2013).Crossref, Medline, CAS, Google Scholar
136 Kanno Y, Vahedi G, Hirahara K, Singleton K, O'shea JJ. Transcriptional and epigenetic control of T helper cell specification: molecular mechanisms underlying commitment and plasticity. Annu. Rev. Immunol. 30, 707–731 (2012).Crossref, Medline, CAS, Google Scholar
137 Invernizzi P, Pasini S, Selmi C, Miozzo M, Podda M. Skewing of X chromosome inactivation in autoimmunity. Autoimmunity 41(4), 272–277 (2008).Crossref, Medline, CAS, Google Scholar
138 Lian X, Xiao R, Hu X et al. DNA demethylation of CD40l in CD4⁺ T cells from women with systemic sclerosis: a possible explanation for female susceptibility. Arthritis Rheum. 64(7), 2338–2345 (2012).Crossref, Medline, CAS, Google Scholar
139 Liao J, Liang G, Xie S et al. CD40L demethylation in CD4(⁺) T cells from women with rheumatoid arthritis. Clin. Immunol. 145(1), 13–18 (2012).Crossref, Medline, CAS, Google Scholar
140 Zhou Y, Yuan J, Pan Y et al. T cell CD40LG gene expression and the production of IgG by autologous B cells in systemic lupus erythematosus. Clin. Immunol. 132(3), 362–370 (2009).Crossref, Medline, CAS, Google Scholar
141 Zhang Y, Zhao M, Sawalha AH, Richardson B, Lu Q. Impaired DNA methylation and its mechanisms in CD4(⁺) T cells of systemic lupus erythematosus. J. Autoimmun. 41, 92–99 (2013).Crossref, Medline, Google Scholar
142 Jones MJ, Goodman SJ, Kobor MS. DNA methylation and healthy human aging. Aging cell 14(6), 924–932 (2015). • The influence of diet and cell metabolism on epigenetic patterns, namely DNA methylation, is demonstrated.Crossref, Medline, CAS, Google Scholar
143 Oaks Z, Perl A. Metabolic control of the epigenome in systemic lupus erythematosus. Autoimmunity 47(4), 256–264 (2014).Crossref, Medline, Google Scholar
144 Strickland FM, Hewagama A, Wu A et al. Diet influences expression of autoimmune-associated genes and disease severity by epigenetic mechanisms in a transgenic mouse model of lupus. Arthritis Rheum. 65(7), 1872–1881 (2013).Crossref, Medline, CAS, Google Scholar
145 Gorelik G, Fang JY, Wu A, Sawalha AH, Richardson B. Impaired T cell protein kinase C delta activation decreases ERK pathway signaling in idiopathic and hydralazine-induced lupus. J. Immunol. 179(8), 5553–5563 (2007).Crossref, Medline, CAS, Google Scholar
146 Wysenbeek AJ, Block DA, Fries JF. Prevalence and expression of photosensitivity in systemic lupus erythematosus. Ann. Rheum. Dis. 48(6), 461–463 (1989).Crossref, Medline, CAS, Google Scholar
147 Zhu X, Li F, Yang B, Liang J, Qin H, Xu J. Effects of ultraviolet B exposure on DNA methylation in patients with systemic lupus erythematosus. Exp. Ther. Med. 5(4), 1219–1225 (2013).Crossref, Medline, CAS, Google Scholar
148 Fan J, Krautkramer KA, Feldman JL, Denu JM. Metabolic regulation of histone post-translational modifications. ACS Chem. Biol. 10(1), 95–108 (2015).Crossref, Medline, CAS, Google Scholar
149 Lu C, Thompson CB. Metabolic regulation of epigenetics. Cell Metab. 16(1), 9–17 (2012).Crossref, Medline, CAS, Google Scholar
150 Ray PD, Huang BW, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell. Signal. 24(5), 981–990 (2012).Crossref, Medline, CAS, Google Scholar
151 Perillo B, Ombra MN, Bertoni A et al. DNA oxidation as triggered by H3K9me2 demethylation drives estrogen-induced gene expression. Science 319(5860), 202–206 (2008).Crossref, Medline, CAS, Google Scholar
152 Gergely P Jr, Grossman C, Niland B et al. Mitochondrial hyperpolarization and ATP depletion in patients with systemic lupus erythematosus. Arthritis Rheum. 46(1), 175–190 (2002).Crossref, Medline, CAS, Google Scholar
153 Griffey RH, Brown MS, Bankhurst AD, Sibbitt RR, Sibbitt WL Jr. Depletion of high-energy phosphates in the central nervous system of patients with systemic lupus erythematosus, as determined by phosphorus-31 nuclear magnetic resonance spectroscopy. Arthritis Rheum. 33(6), 827–833 (1990).Crossref, Medline, CAS, Google Scholar
154 Fernandez DR, Telarico T, Bonilla E et al. Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation. J. Immunol. 182(4), 2063–2073 (2009).Crossref, Medline, CAS, Google Scholar
155 Solomon DH, Kavanaugh AJ, Schur PH, American College of Rheumatology Ad Hoc Committee on Immunologic Testing G. Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing. Arthritis Rheum. 47(4), 434–444 (2002).Crossref, Medline, Google Scholar
156 Bizzaro N, Villalta D, Giavarina D, Tozzoli R. Are anti-nucleosome antibodies a better diagnostic marker than anti-dsDNA antibodies for systemic lupus erythematosus? A systematic review and a study of metanalysis. Autoimmun. Rev. 12(2), 97–106 (2012).Crossref, Medline, CAS, Google Scholar
157 Biesen R, Rose T, Hoyer BF, Alexander T, Hiepe F. Autoantibodies, complement and type I interferon as biomarkers for personalized medicine in SLE. Lupus 25(8), 823–829 (2016).Crossref, Medline, CAS, Google Scholar
158 Wu H, Zhao M, Tan L, Lu Q. The key culprit in the pathogenesis of systemic lupus erythematosus: Aberrant DNA methylation. Autoimmun. Rev. 15(7), 684–689 (2016).Crossref, Medline, CAS, Google Scholar
159 Chechlinska M, Kowalewska M, Nowak R. Systemic inflammation as a confounding factor in cancer biomarker discovery and validation. Nat. Rev. Cancer 10(1), 2–3 (2010).Crossref, Medline, CAS, Google Scholar
160 Ospelt C. Epigenetic biomarkers in rheumatology – the future? Swiss Med. Wkly 146, w14312 (2016).Medline, Google Scholar
161 Mikeska T, Craig JM. DNA methylation biomarkers: cancer and beyond. Genes 5(3), 821–864 (2014).Crossref, Medline, Google Scholar
162 Schwarzenbach H, Hoon DS, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat. Rev. Cancer 11(6), 426–437 (2011).Crossref, Medline, CAS, Google Scholar
163 Zhao M, Zhou Y, Zhu B et al. IFI44L promoter methylation as a blood biomarker for systemic lupus erythematosus. Ann. Rheum. Dis. doi:10.1136/annrheumdis-2015-208410 (2016).Crossref, Google Scholar
164 Zahoor MA, Xue G, Sato H, Murakami T, Takeshima SN, Aida Y. HIV-1 Vpr induces interferon-stimulated genes in human monocyte-derived macrophages. PLoS ONE 9(8), e106418 (2014).Crossref, Medline, Google Scholar
165 Guo Y, Sawalha AH, Lu Q. Epigenetics in the treatment of systemic lupus erythematosus: potential clinical application. Clin. Immunol. 155(1), 79–90 (2014).Crossref, Medline, CAS, Google Scholar
166 Jonsen A, Bengtsson AA, Nived O, Truedsson L, Sturfelt G. Gene-environment interactions in the aetiology of systemic lupus erythematosus. Autoimmunity 40(8), 613–617 (2007).Crossref, Medline, Google Scholar
167 Chafin CB, Regna NL, Hammond SE, Reilly CM. Cellular and urinary microRNA alterations in NZB/W mice with hydroxychloroquine or prednisone treatment. Int. Immunopharmacol. 17(3), 894–906 (2013).Crossref, Medline, CAS, Google Scholar
168 Chan ES, Cronstein BN. Methotrexate – how does it really work? Nat. Rev. Rheumatol. 6(3), 175–178 (2010).Crossref, Medline, CAS, Google Scholar
169 Nihal M, Wu J, Wood GS. Methotrexate inhibits the viability of human melanoma cell lines and enhances Fas/Fas-ligand expression, apoptosis and response to interferon-alpha: rationale for its use in combination therapy. Arch. Biochem. Biophys. 563, 101–107 (2014).Crossref, Medline, CAS, Google Scholar
170 Yang Y, Tang Q, Zhao M et al. The effect of mycophenolic acid on epigenetic modifications in lupus CD4⁺T cells. Clin. Immunol. 158(1), 67–76 (2015).Crossref, Medline, CAS, Google Scholar
171 Zhang J, Yuan B, Zhang F et al. Cyclophosphamide perturbs cytosine methylation in Jurkat-T cells through LSD1-mediated stabilization of DNMT1 protein. Chem. Res. Toxicol. 24(11), 2040–2043 (2011).Crossref, Medline, CAS, Google Scholar
172 Heyn H, Esteller M. DNA methylation profiling in the clinic: applications and challenges. Nat. Rev. Genet. 13(10), 679–692 (2012).Crossref, Medline, CAS, Google Scholar
173 Yamazaki J, Issa JP. Epigenetic aspects of MDS and its molecular targeted therapy. Int. J. Hematol. 97(2), 175–182 (2013).Crossref, Medline, CAS, Google Scholar
174 Nie J, Liu L, Li X, Han W. Decitabine, a new star in epigenetic therapy: the clinical application and biological mechanism in solid tumors. Cancer Lett. 354(1), 12–20 (2014).Crossref, Medline, CAS, Google Scholar
175 Lai ZW, Hanczko R, Bonilla E et al. N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 64(9), 2937–2946 (2012).Crossref, Medline, CAS, Google Scholar
176 Gu Z, Tan W, Ji J et al. Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway. Aging (Albany NY) 8(5), 1102–1114 (2016).Crossref, Medline, CAS, Google Scholar
177 Koga T, Hedrich CM, Mizui M et al. CaMK4-dependent activation of AKT/mTOR and CREM-alpha underlies autoimmunity-associated Th17 imbalance. J. Clin. Invest. 124(5), 2234–2245 (2014).Crossref, Medline, CAS, Google Scholar
178 Verstovsek S. Therapeutic potential of JAK2 inhibitors. Hematology Am. Soc. Hematol. Educ. Program 2009, 636–642 (2009).Crossref, Google Scholar
179 Grabiec AM, Korchynskyi O, Tak PP, Reedquist KA. Histone deacetylase inhibitors suppress rheumatoid arthritis fibroblast-like synoviocyte and macrophage IL-6 production by accelerating mRNA decay. Ann. Rheum. Dis. 71(3), 424–431 (2012).Crossref, Medline, CAS, Google Scholar
180 Grabiec AM, Krausz S, De Jager W et al. Histone deacetylase inhibitors suppress inflammatory activation of rheumatoid arthritis patient synovial macrophages and tissue. J. Immunol. 184(5), 2718–2728 (2010).Crossref, Medline, CAS, Google Scholar
181 Lewis EC, Blaabjerg L, Storling J et al. The oral histone deacetylase inhibitor ITF2357 reduces cytokines and protects islet beta cells in vivo and in vitro. Mol. Med. 17(5–6), 369–377 (2011).Crossref, Medline, CAS, Google Scholar
182 Munro SK, Mitchell MD, Ponnampalam AP. Histone deacetylase inhibition by trichostatin A mitigates LPS induced TNFalpha and IL-10 production in human placental explants. Placenta 34(7), 567–573 (2013).Crossref, Medline, CAS, Google Scholar
183 Mishra N, Reilly CM, Brown DR, Ruiz P, Gilkeson GS. Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. J. Clin. Invest. 111(4), 539–552 (2003).Crossref, Medline, CAS, Google Scholar
184 Salvi V, Bosisio D, Mitola S, Andreoli L, Tincani A, Sozzani S. Trichostatin A blocks type I interferon production by activated plasmacytoid dendritic cells. Immunobiology 215(9–10), 756–761 (2010).Crossref, Medline, CAS, Google Scholar
185 Baechler EC, Batliwalla FM, Karypis G et al. Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. Proc. Natl Acad. Sci. USA 100(5), 2610–2615 (2003).Crossref, Medline, CAS, Google Scholar
186 Schoggins JW, Wilson SJ, Panis M et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472(7344), 481–485 (2011).Crossref, Medline, CAS, Google Scholar
187 Hedrich CM, Ramakrishnan A, Dabitao D, Wang F, Ranatunga D, Bream JH. Dynamic DNA methylation patterns across the mouse and human IL10 genes during CD4⁺ T cell activation; influence of IL-27. Mol. Immunol. 48(1–3), 73–81 (2010).Crossref, Medline, CAS, Google Scholar
188 Hofmann SR, Moller J, Rauen T et al. Dynamic CpG-DNA methylation of Il10 and Il19 in CD4⁺ T lymphocytes and macrophages: effects on tissue-specific gene expression. Klin. Padiatr. 224(2), 53–60 (2012).Crossref, Medline, CAS, Google Scholar
189 Hogg N, Laschinger M, Giles K, Mcdowall A. T-cell integrins: more than just sticking points. J. Cell Sci. 116(Pt 23), 4695–4705 (2003).Crossref, Medline, CAS, Google Scholar
190 Quddus J, Johnson KJ, Gavalchin J et al. Treating activated CD4⁺ T cells with either of two distinct DNA methyltransferase inhibitors, 5-azacytidine or procainamide, is sufficient to cause a lupus-like disease in syngeneic mice. J. Clin. Invest. 92(1), 38–53 (1993).Crossref, Medline, CAS, Google Scholar
191 Richardson B, Powers D, Hooper F, Yung RL, O'rourke K. Lymphocyte function-associated antigen 1 overexpression and T cell autoreactivity. Arthritis Rheum. 37(9), 1363–1372 (1994).Crossref, Medline, CAS, Google Scholar
192 Yung R, Powers D, Johnson K et al. Mechanisms of drug-induced lupus. II. T cells overexpressing lymphocyte function-associated antigen 1 become autoreactive and cause a lupuslike disease in syngeneic mice. J. Clin. Invest. 97(12), 2866–2871 (1996).Crossref, Medline, CAS, Google Scholar
193 Vinuesa CG, Linterman MA, Goodnow CC, Randall KL. T cells and follicular dendritic cells in germinal center B-cell formation and selection. Immunol. Rev. 237(1), 72–89 (2010).Crossref, Medline, CAS, Google Scholar

Vol. 9, No. 4

Metrics

Downloaded 303 times

History

Published online 25 November 2016

Published in print April 2017

Information

Keywords

Acknowledgements

The authors thank C Hedrich for her English-language consultation on this manuscript.

Financial & competing interests disclosure

The work of CM Hedrich is supported by the intramural MeDDrive program, TU Dresden and the Fitz-Thyssen Foundation; GC Tsokos is supported by grants from the National Institutes of Health. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

No writing assistance was utilized in the production of this manuscript.

PDF download

DNA methylation in systemic lupus erythematosus

Abstract

References